Concomitant administration of a fully liquid, ready-to-use DTaP-IPV-HB-PRP-T hexavalent vaccine with a meningococcal serogroup C conjugate vaccine in infants

详细信息    查看全文

• 作者：Timo Vesikari^a ; ^{timo.vesikari@uta.fi} ; Ray Borrow^b ; ^{ray.borrow@phe.gov.uk} ; Xavier Da Costa^c ; ^{xavier.dacosta@sanofipasteur.com} ; Patrick Richard^d ; ^{pr.richard@laposte.net} ; Cé ; cile Eymin^d ; ^{cecile.eymin@neuf.fr} ; Florence Boisnard^d ; ^{fboisnard@spmsd.com} ; Stephen Lockhart^d ; ^{slockhart@spmsd.com}
• 关键词：Immunogenicity ; Safety ; Vaccination ; Hexavalent ; Meningococcal C ; Co-administration
• 刊名：Vaccine
• 出版年：2017
• 出版时间：11 January 2017
• 年：2017
• 卷：35
• 期：3
• 页码：452-458
• 全文大小：577 K
• 卷排序：35

文摘

DTaP-IPV-HB-PRP-T immunogenicity is similar when given concomitantly with a meningococcal C conjugate vaccine or alone. The safety profile of DTaP-IPV-HB-PRP-T is similar when given concomitantly with a meningococcal C conjugate vaccine or alone. These data support the concomitant use of DTa-IPV-HB-PRP-T vaccine with a meningococcal C conjugate vaccine.